Ascentage Pharma Group International (6855.HK) Earnings Analysis
Ascentage Pharma Group International (6855.HK) next reports earnings on 2026-08-26, consensus EPS -0.5019 HKD. Last quarter (2026-03-24) it beat with EPS -1.24823 HKD vs -1.62925 HKD est (+23.4%). It has beaten estimates in 1/1 recent quarters (100%). Trailing P/E -9.29.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6855.HK next report earnings?
| Next earnings date | 2026-08-26 |
|---|---|
| Consensus EPS estimate | -0.5019 HKD |
| Revenue estimate | 0.38B |
6855.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-24 | -1.24823 HKD | -1.62925 HKD | +23.4% | Beat |
| 2025-06-30 | -1.8922 HKD | n/a | n/a | n/a |
| 2024-08-22 | 0.591 HKD | n/a | n/a | n/a |
Beat rate: 1/1 (100%) over reported quarters with consensus data.
6855.HK valuation and analyst view
| Trailing P/E | -9.29 |
|---|---|
| Trailing EPS | -3.32572 HKD |
| Price / book | 8.98 |
| Dividend yield | 0.00% |
| Market cap | 13.99B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ascentage Pharma Group International (6855.HK)'s next earnings date?
Ascentage Pharma Group International is next scheduled to report on 2026-08-26, with a consensus EPS estimate of -0.5019 HKD and revenue estimate of 0.38B.
Did 6855.HK beat earnings last quarter?
In its 2026-03-24 report, 6855.HK posted EPS of -1.24823 HKD versus a -1.62925 HKD estimate — a beat of 23.4%.
What is 6855.HK's earnings track record?
Over the last 1 reported quarters with consensus data, 6855.HK beat estimates 1 times (100%).
What is 6855.HK's current P/E ratio and EPS?
6855.HK trades at a trailing P/E of -9.29 on trailing EPS of -3.3257236814042703 HKD.
What do analysts rate 6855.HK?
6855.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.